
Orforglipron (Foundayo) in Singapore: What to Know

Orforglipron is a once-daily tablet for weight management, sold under the brand name Foundayo. It belongs to the same family of medicines as semaglutide and tirzepatide, the GLP-1 medicines most people know as weekly injections. What sets it apart is that it is a pill you can take at any time of day, with or without food. Here is a clear look at what it is, what the research shows, and where things stand in Singapore.
What is orforglipron?
Orforglipron is a GLP-1 receptor agonist. GLP-1 is a hormone your gut releases after a meal. It tells the brain you are full, slows how quickly the stomach empties, and helps the body manage blood sugar.
Most GLP-1 medicines are peptides, which are small proteins. Stomach acid breaks peptides down, which is why they are usually injected. Orforglipron is different. It is a small-molecule medicine, built to survive digestion and be absorbed as an ordinary tablet. That is why it does not need the strict empty-stomach routine that the existing semaglutide tablet requires.
How does it help with weight?
By acting on GLP-1 receptors, orforglipron works on appetite in three ways:
- Fuller sooner. Meals feel satisfying with smaller portions.
- Fuller for longer. Food leaves the stomach more slowly, so hunger returns later.
- Quieter cravings. Many people notice they think about food less between meals.
Eating less, consistently, is what leads to weight loss. The medicine works best alongside changes to diet, activity and sleep, not instead of them.
What does the research show?
The main study for weight management, ATTAIN-1, followed about 3,000 adults with obesity, or overweight plus a weight-related health problem, who did not have diabetes. Over 72 weeks, people on the highest dose lost about 12% of their body weight on average. People on placebo lost about 1%.
Results vary widely from person to person. Some lose more, some lose less, and a few do not respond much at all. Average figures from a trial are a guide, not a promise.
How it compares with weekly injections
In separate trials, the weekly injections semaglutide 2.4 mg and tirzepatide have produced larger average weight loss than orforglipron. The trials were run in different groups of people, so the numbers cannot be compared directly. For some people, a daily tablet with no injection and no timing rules is easier to stick with, and that matters too.
Is orforglipron approved?
The US Food and Drug Administration (FDA) approved orforglipron for chronic weight management on 1 April 2026. It is approved for adults with obesity, or adults who are overweight with at least one weight-related condition, alongside a reduced-calorie diet and more physical activity. Regulators in the United Kingdom, the United Arab Emirates, Saudi Arabia and China have since approved it as well.
Status in Singapore
At the time of writing (November 2026), orforglipron is not registered with Singapore's Health Sciences Authority (HSA). Until it is, doctors in Singapore cannot prescribe it, and clinics cannot supply it.
Please avoid buying it online or from overseas sellers. Unregistered weight loss products may be fake, wrongly dosed or contaminated, and HSA has warned the public about illegal slimming products many times. If you are interested in orforglipron, the safest step is to speak to a doctor about the options that are available now, and revisit it once it is registered here.
Possible side effects
Side effects are similar to other GLP-1 medicines and mostly affect the gut:
- Nausea
- Constipation or diarrhoea
- Vomiting
- Indigestion or bloating
- Reduced appetite (the intended effect, but it can be strong at first)
These are usually mild to moderate. They tend to show up when treatment starts or the dose goes up, then ease. This is why the dose is started low and increased in steps. In the trials, more people stopped orforglipron because of side effects than stopped the placebo.
As with other medicines in this class, doctors watch for rarer problems such as gallbladder issues and pancreatitis. Long-term data on orforglipron is still being collected, since it is a new medicine.
Who might it suit in future?
Once it is available, orforglipron may suit people who:
- Qualify for medical weight management based on their BMI and health
- Prefer not to inject, or are uncomfortable with needles
- Find fixed morning routines hard, such as shift workers or frequent travellers
- Want to keep their weight stable after an initial course of injections (this is being studied)
In Singapore, doctors use Asian BMI cut-offs, because health risks rise at a lower BMI in Asian populations. A doctor will also look at your blood pressure, blood sugar, cholesterol, medicines and medical history before recommending any weight loss medicine.
What is available in Singapore now?
Several doctor-prescribed options are registered in Singapore today. These include weekly semaglutide injections and weekly tirzepatide injections for weight management. A semaglutide tablet is also registered here, for type 2 diabetes. Each has its own dosing schedule, side effects and suitability. A consultation is the right place to compare them for your situation.
Frequently asked questions
Can I get orforglipron in Singapore now?
No. It is not yet registered with HSA, so it cannot be prescribed or supplied here.
Is it the same as the Rybelsus tablet?
No. Rybelsus is oral semaglutide, a peptide that needs an empty stomach and a 30-minute wait before eating. Orforglipron is a different molecule, a small-molecule medicine with no food or water rules.
Will I regain weight if I stop?
Weight often returns after stopping GLP-1 medicines if eating habits have not changed. Treatment is usually planned as long-term support, with a clear plan for stepping down.
Can I switch from injections to orforglipron later?
Possibly. Trials are looking at whether orforglipron can maintain weight loss after injections. Any switch should be planned by your doctor.
Medically reviewed by Dr Isaac Wong, Founder and Medical Director, The Artisan Clinic. Last updated 17 November 2026. This article is for general education and is not a substitute for medical advice.
Not sure which option fits you?
Orforglipron is not available in Singapore yet, but other doctor-prescribed options are. Book a consultation with an Artisan doctor to review your health, your goals and the treatments that suit you now.


























